Elixinol Wellness Ltd ELLXF

ELLXF OTC
ELLXF
Elixinol Wellness Ltd OTC
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

ELLXF Stock Chart

Trade ELLXF with trusted brokers on TradingView Open account
Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Process Industries
Industry: Agricultural Commodities/Milling
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The firm operates through the following segments: The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.